Ralph Weichselbaum to Androgen Antagonists
This is a "connection" page, showing publications Ralph Weichselbaum has written about Androgen Antagonists.
Connection Strength
0.147
-
Dose-escalated radiotherapy for high-risk prostate cancer: outcomes in modern era with short-term androgen deprivation therapy. Int J Radiat Oncol Biol Phys. 2010 May 01; 77(1):125-30.
Score: 0.069
-
Potency preservation following conformal radiotherapy for localized prostate cancer: impact of neoadjuvant androgen blockade, treatment technique, and patient-related factors. Cancer J Sci Am. 1999 Jul-Aug; 5(4):230-6.
Score: 0.034
-
Radiation oncology. JAMA. 1996 Jun 19; 275(23):1852-3.
Score: 0.028
-
Dose-escalated radiation therapy for intermediate-risk prostate cancer: patient selection for androgen deprivation therapy using percentage of positive cores. Cancer. 2009 Apr 15; 115(8):1784-90.
Score: 0.017